Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thanks again for joining the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. Our presenting -- first presenting company this morning is Ironwood Pharmaceuticals. And it's my pleasure to welcome CEO, Tom McCourt, to talk to us a little bit about the company. There is a Q&A session after the presentation. You can click the icon there to submit questions, and I'll work them in where appropriate. With that, Tom, thanks very much for joining us this morning.
Eric, thanks for having us. And I just want to thank JPMorgan for the opportunity to present to everybody today. For the last year, it's been an absolute privilege to be the new CEO of Ironwood Pharmaceuticals. And even in the midst of the global pandemic, our commitment to advancing the treatment of GI diseases and redefining standard of care for GI patients has been unwavering.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |